| Identification | Back Directory | [Name]
2',3'-Anhydroadenosine | [CAS]
14486-22-7 | [Synonyms]
Anhydro-T
2,3'-Anhydro-T
2'',3''-ANHYDROADENOSINE
2',3'-Anhydroadenosine
2,4(1H,3H)-Pyrimidinedione, 1-(2,3-anhydro-β-D-lyxofuranosyl)-5-methyl-
1-(2,3-Anhydro-beta-D-lyxofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione
9-[(1R,5R)-4α-(Hydroxymethyl)-3,6-dioxabicyclo[3.1.0]hexan-2α-yl]-9H-purin-6-amine
1-[(1R,4R,5R)-4-(hydroxymethyl)-3,6-dioxabicyclo[3.1.0]hex-2-yl]-5-met hyl-pyrimidine-2,4-dione | [Molecular Formula]
C10H12N2O5 | [MOL File]
14486-22-7.mol | [Molecular Weight]
240.21 |
| Chemical Properties | Back Directory | [Melting point ]
143.5-144.5 °C | [density ]
1.505±0.06 g/cm3(Predicted) | [storage temp. ]
Refrigerator | [solubility ]
DMSO, Methanol (slightly) | [form ]
Solid | [pka]
9.44±0.10(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
2'',3''-Anhydroadenosine is an intermediate in synthesizing Cordycepin (C685800), which is the first reported nucleoside antibiotic. |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|